News / Press Releases /
October, 2003
ASINEX announces successful Lead Optimization project with Asahi Kasei
Moscow, October 2003 - ASINEX, a leading European provider of Lead Generation and
Optimization services and products, today announce the signing of a lead optimization
project with Asahi Kasei, one of Japan's leading pharmaceutical companies.
ASINEX are performing optimization of a hit compound provided by Asahi
Kasei at their facilities in Moscow. Several rounds of synthesis have already
been successfully completed, and options for further optimization are being explored.
Dr.Hiroyuki Kouji, General Manager, Laboratory for Medicinal Chemistry, Asahi Kasei said,
"This collaboration with ASINEX has been a significant benefit to our research efforts at
Asahi Kasei. Through our collaboration we were able to identify a number of new lead
compounds of therapeutic interest in a short period of time. We are very happy with the
skill and talents of ASINEX's scientists, and believe their cost-effectiveness and reliability
puts them well ahead of their competition. Asahi Kasei is looking forward to enjoying a long and
fruitful collaboration with ASINEX."
Dr Dimitri Genis, Director of Research at ASINEX commented "We have great respect for
Asahi Kasei as one of the leading Japanese pharmaceutical companies. We are delighted to be
providing chemical services for Asahi Kasei. It is a high priority for us to establish the
service chemistry business of ASINEX in Asia. We look forward to the successful completion
of our project and would look forward to continued work with Asahi Kasei in the future"
About ASINEX
ASINEX (www.asinex.com) is a full-service chemistry provider of 'Intelligent Chemistry`
for the lead generation and optimization stage of drug discovery. Well known as a supplier
of diverse, small molecule libraries for screening and building blocks for combinatorial
chemistry, ASINEX has developed a reputation for cost-effective and efficient Lead Optimization,
Custom Synthesis and Focused Library Generation. Based in Moscow, with a total of 104 chemists (41 PhDs),
8 computational (6 PhDs) chemists and 17 biologists (11 PhDs), ASINEX has powerful drug discovery resources.
About Asahi Kasei
Asahi Kasei (www.asahi-kasei.co.jp) is a US$10 billion technology company, whose mission is
to provide innovative, science-based solutions, contributing to greater quality of life.
Its health care business activities include the discovery, development, manufacture and marketing
of pharmaceutical products, as well as the development, manufacture and marketing of diagnostic
reagents and filtration products. Asahi Kasei is headquartered in Tokyo, Japan.
For more info please contact:
ASINEX Ltd
Alistair Melvin
Business Development Officer
Tel: (00)7 495 780 3411
Fax: (00)7 495 780 3419
Email: amelvin@asinex.com
|